. . . "\u9AD8\u8102\u8840\u75C7"@zh . . . . . . . . "Hyperlipidemia"@en . . . . . . . "1593643"^^ . "Hyperlipidemia is abnormally elevated levels of any or all lipids (fats, cholesterol, or triglycerides) or lipoproteins in the blood. The term hyperlipidemia refers to the laboratory finding itself and is also used as an umbrella term covering any of various acquired or genetic disorders that result in that finding. Hyperlipidemia represents a subset of dyslipidemia and a superset of hypercholesterolemia. Hyperlipidemia is usually chronic and requires ongoing medication to control blood lipid levels. Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism. Hyperlipidemias are divided into primary and secondary subtypes. Primary hyperlipidemia is usually due to genetic causes (such as a mutation in a receptor protein), while secondary hyperlipidemia arises due to other underlying causes such as diabetes. Lipid and lipoprotein abnormalities are common in the general population and are regarded as modifiable risk factors for cardiovascular disease due to their influence on atherosclerosis. In addition, some forms may predispose to acute pancreatitis."@en . "272"^^ . . . . . "Hiperlipidemia (literalki: odolean lipido asko) lipidoen odol-maila altuak eragiten duen gaixotasuna da. Ezin da patologiatzat hartu, gaixotasun askoren bigarren mailakoa izan daitekeen desoreka metabolikotzat edota gaixotasun mota askotan, bereziki kardiobaskularretan eragin dezakeen zerbaitentzat baizik. \"Hiperkolesterolemia\" (kolesterol-maila handiak) eta \"\" (lipoproteina-maila handiak) terminoekin hertsiki lotuta dago. Lipidoak ez daude odolean solte, baizik eta dentsitate txikiko partikula esferiko handietan bilduta, eta partikula horiek odol-ingurunetik bereizten dituzte, hala nola kilomikroiak. Hala, hainbat hiperlipidemia-mota bereizten dira odol-zirkulazioan metatzen diren molekulen arabera. Hiperlipidemia oso ohikoa da biztanlerian, eta gaixotasun kardiobaskularretarako arrisku-f"@eu . . . . . "Hyperlipoprotein\u00E4mie"@de . . . . . . "La hiperlipidemia, hiperlipidosis o hiperlipemia (literalmente: l\u00EDpidos elevados de la sangre) consiste en la presencia de niveles elevados de los l\u00EDpidos en la sangre. No puede considerarse una patolog\u00EDa sino un desajuste metab\u00F3lico que puede ser secundario a muchas enfermedades y puede contribuir a muchas formas de enfermedad, especialmente cardiovasculares. Est\u00E1 estrechamente vinculado a los t\u00E9rminos \u201Chipercolesterolemia\u201D (los niveles elevados de colesterol) e \u201C\u201D (los niveles elevados de lipoprote\u00EDnas).Los l\u00EDpidos no se encuentran sueltos en la sangre sino recogidos en grandes part\u00EDculas esf\u00E9ricas de baja densidad que las separan del medio sangu\u00EDneo, como por ejemplo los quilomicrones. De manera que se distinguen varios tipos de hiperlipidemias seg\u00FAn las mol\u00E9culas que se acumulan en la circulaci\u00F3n sangu\u00EDnea.La hiperlipidemia es muy frecuente en la poblaci\u00F3n y se la considera un gran factor de riesgo para las enfermedades cardiovasculares. La falta de tratamiento puede conducir a diferentes enfermedades cardiacas, al endurecimiento de las arterias (arteriosclerosis), a la pancreatitis o a un ataque cerebral."@es . . "272.4" . . . . . . . "Hyperlipidemia"@en . . . "\u8102\u8CEA\u7570\u5E38\u75C7\uFF08\u3057\u3057\u3064\u3044\u3058\u3087\u3046\u3057\u3087\u3046\u3001\u82F1: dyslipidemia\uFF09\u306F\u3001\u8840\u6DB2\u4E2D\u306B\u542B\u307E\u308C\u308B\u8102\u8CEA\u304C\u904E\u5270\u3001\u3082\u3057\u304F\u306F\u4E0D\u8DB3\u3057\u3066\u3044\u308B\u306A\u3069\u3001\u8102\u8CEA\u4EE3\u8B1D\u306B\u7570\u5E38\u3092\u304D\u305F\u3057\u305F\u72B6\u614B\u3092\u6307\u3059\u30022007\u5E747\u6708\u306B\u9AD8\u8102\u8840\u75C7\uFF08\u82F1: hyperlipidemia\uFF09\u304B\u3089\u8102\u8CEA\u7570\u5E38\u75C7\u306B\u6539\u540D\u3055\u308C\u305F\u3002"@ja . . . . . . . . . . . . "Hiperlipidemia \u2013 zesp\u00F3\u0142 zaburze\u0144 metabolicznych objawiaj\u0105cych si\u0119 podwy\u017Cszonymi poziomami frakcji cholesterolu lub tr\u00F3jgliceryd\u00F3w w surowicy krwi. Najcz\u0119\u015Bciej spowodowana jest nieprawid\u0142owym od\u017Cywianiem, siedz\u0105cym trybem \u017Cycia, nadwag\u0105, predyspozycjami genetycznymi (hipercholesterolemia rodzinna). Prawid\u0142owe warto\u015Bci st\u0119\u017Cenia cholesterolu i trigliceryd\u00F3w W zale\u017Cno\u015Bci od tego, wyr\u00F3\u017Cnia si\u0119 nast\u0119puj\u0105ce typy hiperlipidemii:"@pl . "Hyperlip\u00E9mie"@fr . "\u0413\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F"@ru . . . . "Hyperlipidemi, hyperlipoproteinemi eller dyslipidemi (fettrubbning) \u00E4r f\u00F6rekomsten av f\u00F6rh\u00F6jda eller onormala niv\u00E5er av lipider och/eller lipoproteiner i blodet. Lipider (fettmolekyler) transporteras i en protein-kapsel och densiteten p\u00E5 de inneh\u00E5llande lipiderna best\u00E4mmer partikelns verkan och hur metabolismen p\u00E5verkas. LDL (low-density lipoprotein) verkar genom att f\u00F6ra ut fett fr\u00E5n levern till v\u00E4vnaderna och brukar kallas f\u00F6r det \"onda kolesterolet\" eftersom en h\u00F6g andel LDL i f\u00F6rh\u00E5llande till HDL (som ist\u00E4llet verkar genom att f\u00F6ra kolesterol fr\u00E5n v\u00E4vnader och tillbaka till levern) leder till \u00F6kad risk f\u00F6r ateroskleros. Lipid- och lipoproteinabnormaliteter \u00E4r extremt vanliga i den allm\u00E4nna populationen och ses som en h\u00F6gst modifierbar riskfaktor f\u00F6r kardiovaskul\u00E4r sjukdom. Andra former av dyslipidemi kan predisponera f\u00F6r akut pankreatit."@sv . . . . . . . . . . . "A 4-ml sample of hyperlipidemic blood in a vacutainer with EDTA. Left to settle for four hours without centrifugation, the lipids separated into the top fraction."@en . . . "1124643685"^^ . . "-" . . . . . "D006949"@en . . . . "\u0413\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F"@uk . . . . . . . . "Unter Hyperlipoprotein\u00E4mie (HLP) oder Hyperlipid\u00E4mie versteht man allgemein eine erh\u00F6hte Konzentration des Cholesterins, der Triglyceride und der Lipoproteine mit Verschiebung des relativen Anteils der LDL- bzw. VLDL-Fraktion im Blut. St\u00F6rungen des Lipoproteinstoffwechsels z\u00E4hlen in Deutschland zu den am h\u00E4ufigsten diagnostizierten Krankheiten."@de . . . "Unter Hyperlipoprotein\u00E4mie (HLP) oder Hyperlipid\u00E4mie versteht man allgemein eine erh\u00F6hte Konzentration des Cholesterins, der Triglyceride und der Lipoproteine mit Verschiebung des relativen Anteils der LDL- bzw. VLDL-Fraktion im Blut. Man unterscheidet zwischen prim\u00E4ren und sekund\u00E4ren Hyperlipoprotein\u00E4mien. Prim\u00E4re Hyperlipoprotein\u00E4mien stellen eine eigene, meist genetisch bedingte Erkrankung dar, w\u00E4hrend sekund\u00E4re Hyperlipoprotein\u00E4mien Folgeerscheinungen von anderen Grunderkrankungen sind. Die meisten Patienten mit einer Hyperlipoprotein\u00E4mie weisen eine Kombination aus genetischer Pr\u00E4disposition (oft polygen, siehe Punkt 1) und externen Faktoren (Lebensf\u00FChrung, Krankheiten oder Medikamente, siehe Punkt 2) auf. St\u00F6rungen des Lipoproteinstoffwechsels z\u00E4hlen in Deutschland zu den am h\u00E4ufigsten diagnostizierten Krankheiten."@de . "-"@en . . . . . . "6255" . . . . "\u8102\u8CEA\u7570\u5E38\u75C7"@ja . "Hyperlipidemi"@sv . . . . . . . . . . . ""@en . . . . . "Les hiperlip\u00E8mies, hiperlipoprote\u00EFn\u00E8mies, o hiperlipid\u00E8mies s\u00F3n el grup de dislip\u00E8mies m\u00E9s freq\u00FCents, i consisteixen en la pres\u00E8ncia de nivells elevats o anormals de l\u00EDpids i/o lipoprote\u00EFnes en la sang. Els l\u00EDpids (mol\u00E8cules greixos) s\u00F3n insolubles en la sang, i es transporten dins d'una c\u00E0psula lipoproteica, i la densitat dels l\u00EDpids i el tipus de prote\u00EFna determinen la sort de la part\u00EDcula i la seva influ\u00E8ncia en les anomalies del metabolisme."@ca . . . . . "272.0" . . . "Iperlipoproteinemia"@it . . "D006949" . . "E78."@en . . . . "272.4"^^ . . . . . . . . . . . . . . . . . . . . . . . . "Hiperlipidemia (literalki: odolean lipido asko) lipidoen odol-maila altuak eragiten duen gaixotasuna da. Ezin da patologiatzat hartu, gaixotasun askoren bigarren mailakoa izan daitekeen desoreka metabolikotzat edota gaixotasun mota askotan, bereziki kardiobaskularretan eragin dezakeen zerbaitentzat baizik. \"Hiperkolesterolemia\" (kolesterol-maila handiak) eta \"\" (lipoproteina-maila handiak) terminoekin hertsiki lotuta dago. Lipidoak ez daude odolean solte, baizik eta dentsitate txikiko partikula esferiko handietan bilduta, eta partikula horiek odol-ingurunetik bereizten dituzte, hala nola kilomikroiak. Hala, hainbat hiperlipidemia-mota bereizten dira odol-zirkulazioan metatzen diren molekulen arabera. Hiperlipidemia oso ohikoa da biztanlerian, eta gaixotasun kardiobaskularretarako arrisku-faktore handitzat jotzen da. Tratamendurik ezak bihotzeko gaixotasun desberdinak, arteriak gogortzea (arteriosklerosia), pankreatitisa edo garuneko traumatismoa eragin ditzake."@eu . "Hyperlipidemia"@en . . . . . . . . "L\u2019hyperlip\u00E9mie ou hyperlipid\u00E9mie est le nom donn\u00E9 \u00E0 des dysfonctionnements se traduisant par un taux \u00E9lev\u00E9 de graisse dans le sang (sous forme de lipoprot\u00E9ines, c'est pourquoi on parle aussi d'hyperlipoprot\u00E9in\u00E9mie). C'est une maladie de plus en plus commune dans les pays riches et d\u00E9velopp\u00E9s (4 % des adultes de plus de 30 ans sont par exemple concern\u00E9s en France). C'est un probl\u00E8me grave car facteur de risque d\u2019 (premi\u00E8re cause de mortalit\u00E9 dans de nombreux pays riches)."@fr . . . . . . . . . . . . . "6255"^^ . . . . . . . . . . . "E78." . . . . . . . . . "Per iperlipoproteinemia si intendono livelli anormalmente elevati di alcuni o tutti i lipidi o lipoproteine nel sangue. \u00C8 la forma pi\u00F9 comune di dislipidemia (che include qualsiasi livello lipidico anormale). I lipidi (molecole insolubili in acqua) vengono trasportati in una capsula proteica. La dimensione di quella capsula, o lipoproteina, determina la sua densit\u00E0. La densit\u00E0 delle lipoproteine e il tipo di apolipoproteine che contiene determinano il destino della particella e la sua influenza sul metabolismo."@it . . . . . . . . . "\u9AD8\u8102\u8840\u75C7\uFF08Hyperlipidemia\uFF0C\u82F1\u5F0F\u82F1\u6587\u70BA Hyperlipidaemia\uFF09\u53C8\u7A31\u9AD8\u8102\u86CB\u767D\u8840\u75C7\uFF08Hyperlipoproteinemia\uFF09\uFF0C\u4FD7\u7A31\u8840\u8102\u904E\u9AD8\u3001\u9AD8\u8840\u8102\uFF0C\u662F\u6307\u6D89\u53CA\u8840\u6DB2\u4EFB\u4F55\u6216\u6240\u6709\u8102\u985E\u4EE5\u53CA\u53C8\u6216\u8102\u86CB\u767D\u7570\u5E38\u5347\u9AD8\u6C34\u5E73\u7684\u60C5\u6CC1\uFF0C\u662F\u8840\u8102\u7570\u5E38\uFF08Dyslipidemia\uFF09\u6700\u5E38\u898B\u7684\u5F62\u5F0F\uFF08\u5176\u4E2D\u5305\u62EC\u4EFB\u4F55\u7570\u5E38\u8102\u8CEA\u6C34\u5E73\uFF09\u3002\u8102\u8CEA\uFF08\u8102\u6EB6\u6027\u5206\u5B50\uFF09\u7531 \u8F7D\u8102\u86CB\u767D\u904B\u9001\u3002 \u8F7D\u8102\u86CB\u767D\u5BC6\u5EA6\u53CA\u7ED3\u6784\u7C7B\u578B\u6C7A\u5B9A\u8BE5\u8F7D\u8102\u86CB\u767D\u5982\u4F55\u5C0D\u4EE3\u8B1D\u4EA7\u751F\u5F71\u97FF\u3002\u8840\u4E2D\u8102\u8D28(Lipid)\u4E3B\u8981\u7684\u6210\u5206\u6709\u81BD\u56FA\u9187(cholesterol; CE)\u3001\u4E09\u9178\u7518\u6CB9\u916F(triglyceride; TG)\u8207\u542B\u78F7\u8102\u7C7B(phospholipid)\uFF0C\u56E0\u4E0D\u6EB6\u65BC\u6C34\uFF0C\u5FC5\u9808\u5148\u8207\u8F7D\u8102\u86CB\u767DA\u0406\u3001\u8F7D\u8102\u86CB\u767DB100\u7D50\u5408\u6210\u53EF\u6EB6\u6027\u7684\u8102\u86CB\u767D(Lipoprotein)\u624D\u53EF\u904B\u884C\u65BC\u8840\u6DB2\u4E2D\uFF0C\u8F38\u9001\u5230\u5168\u8EAB\u5404\u90E8\u4F4D\u3002\u9AD8\u5BC6\u5EA6\u8102\u86CB\u767D(HDL-C)\u53EF\u4EE5\u79FB\u9664\u8840\u6DB2\u4E2D\u591A\u7684\u81BD\u56FA\u9187\uFF0C\u800C\u4F4E\u5BC6\u5EA6\u8102\u86CB\u767D(LDL-C)\u542B\u6709\u5927\u91CF\u81BD\u56FA\u9187\uFF0C\u5BB9\u6613\u9020\u6210\u52D5\u8108\u7CA5\u6837\u786C\u5316\u3002\u3002 \u8102\u86CB\u767D\u4F9D\u5176\u7D44\u6210\u53CA\u5BC6\u5EA6\u4E4B\u4E0D\u540C\u53EF\u5206\u70BA\u4E94\u985E\uFF1A\u4E73\u7CDC\u5FAE\u7C92(chylomicron; CM)\u3001\u6975\u4F4E\u5BC6\u5EA6\u8102\u86CB\u767D(very low density lipoprotein; VLDL)\u3001\u4F4E\u5BC6\u5EA6\u8102\u86CB\u767D(low density lipoprotein; LDL)\u3001\u4E2D\u5BC6\u5EA6\u8102\u86CB\u767D(intermediate density lipoprotein; IDL)\u3001\u9AD8\u5BC6\u5EA6\u8102\u86CB\u767D(high density lipoprotein; HDL\u3002\u3002 \u9AD8\u8102\u8840\u75C7\u5206\u70BA\u300C\u539F\u767C\u6027\u300D\u548C\u300C\u7E7C\u767C\u6027\u4E9E\u578B\u300D\u3002\u539F\u767C\u6027\u9AD8\u8102\u8840\u75C7\u901A\u5E38\u4F86\u81EA\u65BC\u907A\u50B3\u539F\u56E0\uFF08\u4F8B\u5982\u5728\u53D7\u9AD4\u86CB\u767D\u4E2D\u7684\u7A81\u8B8A\uFF09\uFF0C\u800C\u7E7C\u767C\u6027\u9AD8\u8102\u8840\u75C7\u7684\u7522\u751F\u662F\u7531\u65BC\u5176\u5B83\u7684\u539F\u56E0\uFF0C\u5982\u7CD6\u5C3F\u75C5\u3002\u8102\u8CEA\u548C\u8102\u86CB\u767D\u7570\u5E38\u662F\u5728\u4E00\u822C\u4EBA\u7FA4\u8F03\u5E38\u898B\u7684\uFF0C\u4E26\u4E14\u88AB\u8A8D\u70BA\u662F\u5FC3\u8840\u7BA1\u75BE\u75C5\u7684\u4E00\u500B\u6539\u8B8A\u7684\u5371\u96AA\u56E0\u7D20\u3001\u8D77\u65BC\u52A8\u8109\u7CA5\u6837\u786C\u5316\u5C0D\u5B83\u5011\u767C\u751F\u5F71\u97FF\u3002\u6B64\u5916\uFF0C\u67D0\u4E9B\u5F62\u5F0F\u7684\u9AD8\u8102\u8840\u75C7\u53EF\u80FD\u8A98\u767C\u3002"@zh . . . . . . . . . . . "\uACE0\uC9C0\uD608\uC99D(\u9AD8\u8102\u8840\u75C7, \uC601\uC5B4: hyperlipidemia, hyperlipoproteinemia, hyperlipidaemia)\uC740 \uD544\uC694 \uC774\uC0C1\uC758 \uC9C0\uBC29\uC131\uBD84 \uBB3C\uC9C8\uC774 \uD608\uC561\uC5D0 \uC874\uC7AC\uD558\uC5EC \uC5FC\uC99D\uC744 \uC77C\uC73C\uD0A4\uB294 \uC0C1\uD0DC \uB610\uB294 \uD608\uCCAD \uC18D\uC5D0 \uC9C0\uBC29\uC9C8\uC774 \uB9CE\uC544\uC11C \uD608\uCCAD\uC774 \uD63C\uD0C1\uD574\uC9C4 \uC0C1\uD0DC\uB97C \uB9D0\uD55C\uB2E4. \uACE0\uC9C0\uC9C8 \uD608\uC99D(\u9AD8\u8102\u8CEA\u8840\u75C7)\uC774\uB77C\uACE0\uB3C4 \uD55C\uB2E4. \uACF5\uBCF5\uC2DC \uD608\uCCAD \uCF5C\uB808\uC2A4\uD14C\uB864\uC774 220 mg/dl \uC774\uC0C1\uC774\uAC70\uB098 \uC911\uC131\uC9C0\uBC29\uC774 150 mg/dl\uC774\uC0C1\uC778 \uACBD\uC6B0 \uACE0\uC9C0\uD608\uC99D\uC73C\uB85C \uC9C4\uB2E8\uD55C\uB2E4. \uACE0\uC9C0\uD608\uC99D\uC740 \uADF8 \uC790\uCCB4\uB85C \uD2B9\uBCC4\uD55C \uC99D\uC0C1\uC774 \uB098\uD0C0\uB098\uC9C0\uB294 \uC54A\uC9C0\uB9CC, \uACE0\uD608\uC555, \uB3D9\uB9E5\uACBD\uD654, \uB1CC\uC878\uC911 \uB4F1\uC744 \uCD09\uC9C4\uC2DC\uD0A4\uB294 \uC704\uD5D8\uC694\uC778\uC73C\uB85C\uC11C \uC2EC\uD608\uAD00\uACC4 \uC9C8\uD658\uC5D0 \uC758\uD55C \uC0AC\uB9DD\uC728\uC744 \uC720\uC758\uD558\uAC8C \uC99D\uAC00\uC2DC\uD0A8\uB2E4. \uC774 \uBCD1\uC744 \uCE58\uB8CC\uD558\uAE30 \uC704\uD574\uC11C\uB294 \uC6B4\uB3D9\uC694\uBC95\uACFC \uC2DD\uC774\uC694\uBC95\uC774 \uBCD1\uD589\uB418\uC5B4\uC57C \uD558\uBA70, \uB2EC\uCF64\uD55C \uC74C\uC2DD\uC774\uB098 \uC54C\uCF54\uC62C \uC74C\uB8CC \uB4F1\uC744 \uD53C\uD574\uC57C \uD55C\uB2E4. \uB2E4\uB9CC, \uC9C0\uC9C8\uC758 \uB18D\uB3C4\uAC00 \uAD00\uB9AC\uB418\uC9C0 \uC54A\uB294 \uD658\uC790\uB4E4\uC740 \uC2A4\uD0C0\uD2F4(statin)\uC744 \uBE44\uB86F\uD55C \uC57D\uC744 \uC774\uC6A9\uD558\uC5EC \uD608\uC911 \uC9C0\uC9C8\uC744 \uC870\uC808\uD558\uC5EC \uC2EC\uD608\uAD00\uACC4 \uC9C8\uD658\uC758 \uC704\uD5D8\uC131\uC744 \uB0AE\uCD9C \uD544\uC694\uAC00 \uC788\uB2E4."@ko . . . . "Per iperlipoproteinemia si intendono livelli anormalmente elevati di alcuni o tutti i lipidi o lipoproteine nel sangue. \u00C8 la forma pi\u00F9 comune di dislipidemia (che include qualsiasi livello lipidico anormale). I lipidi (molecole insolubili in acqua) vengono trasportati in una capsula proteica. La dimensione di quella capsula, o lipoproteina, determina la sua densit\u00E0. La densit\u00E0 delle lipoproteine e il tipo di apolipoproteine che contiene determinano il destino della particella e la sua influenza sul metabolismo. Le iperlipidemie sono suddivise in sottotipi primari e secondari. L'iperlipidemia primaria \u00E8 solitamente dovuta a cause genetiche (come una mutazione in una proteina recettoriale), mentre l'iperlipidemia secondaria sorge a causa di altre cause sottostanti come il diabete. Le anormalit\u00E0 lipidiche e lipoproteiche sono comuni nella popolazione generale e sono considerati fattori di rischio modificabili per le malattie cardiovascolari a causa della loro influenza sull'aterosclerosi. Inoltre, alcune forme possono predisporre alla pancreatite acuta. I disturbi sono spesso autosomici recessivi. L'alterazione si pu\u00F2 manifestare come ipertrigliceridemia, ipercolesterolemia o entrambe."@it . . . . . . . . . . . . . . . . . . . . . . . . . . "Hiperlipidosis"@es . . . . "Hiperlipidemia"@eu . . . . "Hyperlipidemi, hyperlipoproteinemi eller dyslipidemi (fettrubbning) \u00E4r f\u00F6rekomsten av f\u00F6rh\u00F6jda eller onormala niv\u00E5er av lipider och/eller lipoproteiner i blodet. Lipider (fettmolekyler) transporteras i en protein-kapsel och densiteten p\u00E5 de inneh\u00E5llande lipiderna best\u00E4mmer partikelns verkan och hur metabolismen p\u00E5verkas. LDL (low-density lipoprotein) verkar genom att f\u00F6ra ut fett fr\u00E5n levern till v\u00E4vnaderna och brukar kallas f\u00F6r det \"onda kolesterolet\" eftersom en h\u00F6g andel LDL i f\u00F6rh\u00E5llande till HDL (som ist\u00E4llet verkar genom att f\u00F6ra kolesterol fr\u00E5n v\u00E4vnader och tillbaka till levern) leder till \u00F6kad risk f\u00F6r ateroskleros."@sv . "\uACE0\uC9C0\uD608\uC99D"@ko . "\u0413\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F, \u0442\u0430\u043A\u043E\u0436 \u0433\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0435\u043C\u0456\u044F, \u0434\u0438\u0441\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F \u2014 \u0430\u043D\u043E\u043C\u0430\u043B\u044C\u043D\u043E \u043F\u0456\u0434\u0432\u0438\u0449\u0435\u043D\u0438\u0439 \u0440\u0456\u0432\u0435\u043D\u044C \u043B\u0456\u043F\u0456\u0434\u0456\u0432 \u0442\u0430/\u0430\u0431\u043E \u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0456\u0432 \u0443 \u043A\u0440\u043E\u0432\u0456 \u043B\u044E\u0434\u0438\u043D\u0438. \u0404 \u0441\u0438\u043D\u0434\u0440\u043E\u043C\u043E\u043C \u0434\u0435\u044F\u043A\u0438\u0445 \u0445\u0432\u043E\u0440\u043E\u0431. \u041F\u043E\u0440\u0443\u0448\u0435\u043D\u043D\u044F \u043E\u0431\u043C\u0456\u043D\u0443 \u043B\u0456\u043F\u0456\u0434\u0456\u0432 \u0442\u0430 \u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0456\u0432 \u0437\u0443\u0441\u0442\u0440\u0456\u0447\u0430\u0454\u0442\u044C\u0441\u044F \u0434\u043E\u0432\u043E\u043B\u0456 \u0447\u0430\u0441\u0442\u043E \u0443 \u0437\u0430\u0433\u0430\u043B\u044C\u043D\u0456\u0439 \u043F\u043E\u043F\u0443\u043B\u044F\u0446\u0456\u0457. \u0413\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F \u0454 \u0432\u0430\u0436\u043B\u0438\u0432\u0438\u043C \u0444\u0430\u043A\u0442\u043E\u0440\u043E\u043C \u0440\u0438\u0437\u0438\u043A\u0443 \u0440\u043E\u0437\u0432\u0438\u0442\u043A\u0443 \u0441\u0435\u0440\u0446\u0435\u0432\u043E-\u0441\u0443\u0434\u0438\u043D\u043D\u0438\u0445 \u0437\u0430\u0445\u0432\u043E\u0440\u044E\u0432\u0430\u043D\u044C \u0443 \u0437\u0432'\u044F\u0437\u043A\u0443 \u0437\u0456 \u0437\u043D\u0430\u0447\u043D\u0438\u043C \u0432\u043F\u043B\u0438\u0432\u043E\u043C \u0445\u043E\u043B\u0435\u0441\u0442\u0435\u0440\u0438\u043D\u0443 \u043D\u0430 \u0440\u043E\u0437\u0432\u0438\u0442\u043E\u043A \u0430\u0442\u0435\u0440\u043E\u0441\u043A\u043B\u0435\u0440\u043E\u0437\u0443. \u041A\u0440\u0456\u043C \u0446\u044C\u043E\u0433\u043E, \u0434\u0435\u044F\u043A\u0456 \u0433\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u0457 \u0432\u043F\u043B\u0438\u0432\u0430\u044E\u0442\u044C \u043D\u0430 \u0440\u043E\u0437\u0432\u0438\u0442\u043E\u043A \u0433\u043E\u0441\u0442\u0440\u043E\u0433\u043E \u043F\u0430\u043D\u043A\u0440\u0435\u0430\u0442\u0438\u0442\u0443."@uk . "Hiperlip\u00E8mia"@ca . . . . . . "\u8102\u8CEA\u7570\u5E38\u75C7\uFF08\u3057\u3057\u3064\u3044\u3058\u3087\u3046\u3057\u3087\u3046\u3001\u82F1: dyslipidemia\uFF09\u306F\u3001\u8840\u6DB2\u4E2D\u306B\u542B\u307E\u308C\u308B\u8102\u8CEA\u304C\u904E\u5270\u3001\u3082\u3057\u304F\u306F\u4E0D\u8DB3\u3057\u3066\u3044\u308B\u306A\u3069\u3001\u8102\u8CEA\u4EE3\u8B1D\u306B\u7570\u5E38\u3092\u304D\u305F\u3057\u305F\u72B6\u614B\u3092\u6307\u3059\u30022007\u5E747\u6708\u306B\u9AD8\u8102\u8840\u75C7\uFF08\u82F1: hyperlipidemia\uFF09\u304B\u3089\u8102\u8CEA\u7570\u5E38\u75C7\u306B\u6539\u540D\u3055\u308C\u305F\u3002"@ja . . . . . . . . . . . . . . . . . . "150"^^ . . . . . "\u0641\u0631\u0637 \u0634\u062D\u0645\u064A\u0627\u062A \u0627\u0644\u062F\u0645 \u0623\u0648 \u0641\u0631\u0637 \u0628\u0631\u0648\u062A\u064A\u0646\u0627\u062A \u0627\u0644\u062F\u0645 \u0627\u0644\u0634\u062D\u0645\u064A\u0629 \u0647\u0648 \u062D\u0627\u0644\u0629 \u0627\u0631\u062A\u0641\u0627\u0639 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0623\u064A \u0623\u0648 \u0643\u0644 \u0645\u0646 \u0627\u0644\u062F\u0647\u0648\u0646 \u0628\u0634\u0643\u0644 \u063A\u064A\u0631 \u0637\u0628\u064A\u0639\u064A \u0623\u0648 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A \u0641\u064A \u0627\u0644\u062F\u0645 \u0648\u0647\u0648 \u0627\u0644\u0634\u0643\u0644 \u0627\u0644\u0623\u0643\u062B\u0631 \u0634\u064A\u0648\u0639\u0627 \u0645\u0646 \u0627\u0631\u062A\u0641\u0627\u0639 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646 \u0641\u064A \u0627\u0644\u062F\u0645\u060C (\u0627\u0644\u0630\u064A \u0623\u064A\u0636\u0627 \u064A\u062A\u0636\u0645\u0646 \u0623\u064A \u0627\u0646\u062E\u0641\u0627\u0636 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646). \u062A\u0646\u0642\u0644 \u0627\u0644\u062F\u0647\u0648\u0646 (\u062C\u0632\u064A\u0626\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646 \u0627\u0644\u0642\u0627\u0628\u0644\u0629 \u0644\u0644\u0630\u0648\u0628\u0627\u0646) \u0641\u064A \u063A\u0634\u0627\u0621 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0648\u064A\u062D\u062F\u062F \u0643\u062B\u0627\u0641\u062A\u0647 \u062D\u062C\u0645 \u062A\u0644\u0643 \u0627\u0644\u0643\u0628\u0633\u0648\u0644\u0629 \u0623\u0648 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A. \u064A\u062D\u062A\u0648\u064A \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A \u0648\u0646\u0648\u0639 \u0635\u0645\u064A\u0645 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u0634\u062D\u0645\u064A \u0639\u0644\u0649 \u062A\u062D\u062F\u064A\u062F \u0645\u0635\u064A\u0631 \u0627\u0644\u062C\u0633\u064A\u0645\u0627\u062A \u0648\u062A\u0623\u062B\u064A\u0631\u0647\u0627 \u0639\u0644\u0649 \u0639\u0645\u0644\u064A\u0629 \u0627\u0644\u062A\u0645\u062B\u064A\u0644 \u0627\u0644\u063A\u0630\u0627\u0626\u064A."@ar . . . . . . . . . . . . . . "L\u2019hyperlip\u00E9mie ou hyperlipid\u00E9mie est le nom donn\u00E9 \u00E0 des dysfonctionnements se traduisant par un taux \u00E9lev\u00E9 de graisse dans le sang (sous forme de lipoprot\u00E9ines, c'est pourquoi on parle aussi d'hyperlipoprot\u00E9in\u00E9mie). C'est une maladie de plus en plus commune dans les pays riches et d\u00E9velopp\u00E9s (4 % des adultes de plus de 30 ans sont par exemple concern\u00E9s en France). C'est un probl\u00E8me grave car facteur de risque d\u2019 (premi\u00E8re cause de mortalit\u00E9 dans de nombreux pays riches)."@fr . . . "36949"^^ . . "La hiperlipidemia, hiperlipidosis o hiperlipemia (literalmente: l\u00EDpidos elevados de la sangre) consiste en la presencia de niveles elevados de los l\u00EDpidos en la sangre. No puede considerarse una patolog\u00EDa sino un desajuste metab\u00F3lico que puede ser secundario a muchas enfermedades y puede contribuir a muchas formas de enfermedad, especialmente cardiovasculares. Est\u00E1 estrechamente vinculado a los t\u00E9rminos \u201Chipercolesterolemia\u201D (los niveles elevados de colesterol) e \u201C\u201D (los niveles elevados de lipoprote\u00EDnas).Los l\u00EDpidos no se encuentran sueltos en la sangre sino recogidos en grandes part\u00EDculas esf\u00E9ricas de baja densidad que las separan del medio sangu\u00EDneo, como por ejemplo los quilomicrones. De manera que se distinguen varios tipos de hiperlipidemias seg\u00FAn las mol\u00E9culas que se acumulan en la "@es . . . "\u0413\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F (\u0433\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u0435\u043C\u0438\u044F, \u0434\u0438\u0441\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F) \u2014 \u0430\u043D\u043E\u043C\u0430\u043B\u044C\u043D\u043E \u043F\u043E\u0432\u044B\u0448\u0435\u043D\u043D\u044B\u0439 \u0443\u0440\u043E\u0432\u0435\u043D\u044C \u043B\u0438\u043F\u0438\u0434\u043E\u0432 \u0438/\u0438\u043B\u0438 \u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u043E\u0432 \u0432 \u043A\u0440\u043E\u0432\u0438 \u0447\u0435\u043B\u043E\u0432\u0435\u043A\u0430. \u041D\u0430\u0440\u0443\u0448\u0435\u043D\u0438\u0435 \u043E\u0431\u043C\u0435\u043D\u0430 \u043B\u0438\u043F\u0438\u0434\u043E\u0432 \u0438 \u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u043E\u0432 \u0432\u0441\u0442\u0440\u0435\u0447\u0430\u0435\u0442\u0441\u044F \u0434\u043E\u0432\u043E\u043B\u044C\u043D\u043E \u0447\u0430\u0441\u0442\u043E \u0432 \u043E\u0431\u0449\u0435\u0439 \u043F\u043E\u043F\u0443\u043B\u044F\u0446\u0438\u0438. \u0413\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F \u044F\u0432\u043B\u044F\u0435\u0442\u0441\u044F \u0432\u0430\u0436\u043D\u044B\u043C \u0444\u0430\u043A\u0442\u043E\u0440\u043E\u043C \u0440\u0438\u0441\u043A\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u044F \u0441\u0435\u0440\u0434\u0435\u0447\u043D\u043E-\u0441\u043E\u0441\u0443\u0434\u0438\u0441\u0442\u044B\u0445 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0439 \u0432 \u043E\u0441\u043D\u043E\u0432\u043D\u043E\u043C \u0432 \u0441\u0432\u044F\u0437\u0438 \u0441\u043E \u0437\u043D\u0430\u0447\u0438\u0442\u0435\u043B\u044C\u043D\u044B\u043C \u0432\u043B\u0438\u044F\u043D\u0438\u0435\u043C \u0445\u043E\u043B\u0435\u0441\u0442\u0435\u0440\u0438\u043D\u0430 \u043D\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u0430\u0442\u0435\u0440\u043E\u0441\u043A\u043B\u0435\u0440\u043E\u0437\u0430. \u041A\u0440\u043E\u043C\u0435 \u044D\u0442\u043E\u0433\u043E, \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0435 \u0433\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u0438 \u0432\u043B\u0438\u044F\u044E\u0442 \u043D\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u043E\u0441\u0442\u0440\u043E\u0433\u043E \u043F\u0430\u043D\u043A\u0440\u0435\u0430\u0442\u0438\u0442\u0430."@ru . . . . . . "Hyperlipoproteinemia, hyperlipidaemia"@en . . . . . . . . . . . . . . . . . . . "Hyperlipidemia is abnormally elevated levels of any or all lipids (fats, cholesterol, or triglycerides) or lipoproteins in the blood. The term hyperlipidemia refers to the laboratory finding itself and is also used as an umbrella term covering any of various acquired or genetic disorders that result in that finding. Hyperlipidemia represents a subset of dyslipidemia and a superset of hypercholesterolemia. Hyperlipidemia is usually chronic and requires ongoing medication to control blood lipid levels."@en . . . "\u0641\u0631\u0637 \u0634\u062D\u0645\u064A\u0627\u062A \u0627\u0644\u062F\u0645"@ar . . . . . "\u0641\u0631\u0637 \u0634\u062D\u0645\u064A\u0627\u062A \u0627\u0644\u062F\u0645 \u0623\u0648 \u0641\u0631\u0637 \u0628\u0631\u0648\u062A\u064A\u0646\u0627\u062A \u0627\u0644\u062F\u0645 \u0627\u0644\u0634\u062D\u0645\u064A\u0629 \u0647\u0648 \u062D\u0627\u0644\u0629 \u0627\u0631\u062A\u0641\u0627\u0639 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0623\u064A \u0623\u0648 \u0643\u0644 \u0645\u0646 \u0627\u0644\u062F\u0647\u0648\u0646 \u0628\u0634\u0643\u0644 \u063A\u064A\u0631 \u0637\u0628\u064A\u0639\u064A \u0623\u0648 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A \u0641\u064A \u0627\u0644\u062F\u0645 \u0648\u0647\u0648 \u0627\u0644\u0634\u0643\u0644 \u0627\u0644\u0623\u0643\u062B\u0631 \u0634\u064A\u0648\u0639\u0627 \u0645\u0646 \u0627\u0631\u062A\u0641\u0627\u0639 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646 \u0641\u064A \u0627\u0644\u062F\u0645\u060C (\u0627\u0644\u0630\u064A \u0623\u064A\u0636\u0627 \u064A\u062A\u0636\u0645\u0646 \u0623\u064A \u0627\u0646\u062E\u0641\u0627\u0636 \u0645\u0633\u062A\u0648\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646). \u062A\u0646\u0642\u0644 \u0627\u0644\u062F\u0647\u0648\u0646 (\u062C\u0632\u064A\u0626\u064A\u0627\u062A \u0627\u0644\u062F\u0647\u0648\u0646 \u0627\u0644\u0642\u0627\u0628\u0644\u0629 \u0644\u0644\u0630\u0648\u0628\u0627\u0646) \u0641\u064A \u063A\u0634\u0627\u0621 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0648\u064A\u062D\u062F\u062F \u0643\u062B\u0627\u0641\u062A\u0647 \u062D\u062C\u0645 \u062A\u0644\u0643 \u0627\u0644\u0643\u0628\u0633\u0648\u0644\u0629 \u0623\u0648 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A. \u064A\u062D\u062A\u0648\u064A \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A \u0648\u0646\u0648\u0639 \u0635\u0645\u064A\u0645 \u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u0634\u062D\u0645\u064A \u0639\u0644\u0649 \u062A\u062D\u062F\u064A\u062F \u0645\u0635\u064A\u0631 \u0627\u0644\u062C\u0633\u064A\u0645\u0627\u062A \u0648\u062A\u0623\u062B\u064A\u0631\u0647\u0627 \u0639\u0644\u0649 \u0639\u0645\u0644\u064A\u0629 \u0627\u0644\u062A\u0645\u062B\u064A\u0644 \u0627\u0644\u063A\u0630\u0627\u0626\u064A. \u0648\u0634\u0630\u0648\u0630 \u0627\u0644\u062F\u0647\u0648\u0646 \u0648\u0627\u0644\u0628\u0631\u0648\u062A\u064A\u0646 \u0627\u0644\u062F\u0647\u0646\u064A \u0634\u0627\u0626\u0639 \u0628\u064A\u0646 \u0639\u0627\u0645\u0629 \u0627\u0644\u0646\u0627\u0633\u060C \u0648\u064A\u0639\u062A\u0628\u0631 \u0639\u0627\u0645\u0644 \u062E\u0637\u0648\u0631\u0629 \u0642\u0627\u0628\u0644 \u0644\u0644\u062A\u0639\u062F\u064A\u0644 \u0648\u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0645\u0631\u0627\u0636 \u0627\u0644\u0642\u0644\u0628 \u0648\u0627\u0644\u0623\u0648\u0639\u064A\u0629 \u0627\u0644\u062F\u0645\u0648\u064A\u0629 \u0646\u0638\u0631\u0627 \u0644\u062A\u0623\u062B\u064A\u0631\u0647 \u0639\u0644\u0649 \u0627\u0644\u062A\u0635\u0644\u0628 \u0627\u0644\u062A\u0639\u0635\u062F\u064A. \u0648\u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u0630\u0644\u0643\u060C \u0628\u0639\u0636 \u0635\u0648\u0631\u0647 \u0642\u062F \u062A\u0639\u0631\u0636 \u0644\u0627\u0644\u062A\u0647\u0627\u0628 \u062D\u0627\u062F \u0641\u064A \u0627\u0644\u0628\u0646\u0643\u0631\u064A\u0627\u0633."@ar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "\u9AD8\u8102\u8840\u75C7\uFF08Hyperlipidemia\uFF0C\u82F1\u5F0F\u82F1\u6587\u70BA Hyperlipidaemia\uFF09\u53C8\u7A31\u9AD8\u8102\u86CB\u767D\u8840\u75C7\uFF08Hyperlipoproteinemia\uFF09\uFF0C\u4FD7\u7A31\u8840\u8102\u904E\u9AD8\u3001\u9AD8\u8840\u8102\uFF0C\u662F\u6307\u6D89\u53CA\u8840\u6DB2\u4EFB\u4F55\u6216\u6240\u6709\u8102\u985E\u4EE5\u53CA\u53C8\u6216\u8102\u86CB\u767D\u7570\u5E38\u5347\u9AD8\u6C34\u5E73\u7684\u60C5\u6CC1\uFF0C\u662F\u8840\u8102\u7570\u5E38\uFF08Dyslipidemia\uFF09\u6700\u5E38\u898B\u7684\u5F62\u5F0F\uFF08\u5176\u4E2D\u5305\u62EC\u4EFB\u4F55\u7570\u5E38\u8102\u8CEA\u6C34\u5E73\uFF09\u3002\u8102\u8CEA\uFF08\u8102\u6EB6\u6027\u5206\u5B50\uFF09\u7531 \u8F7D\u8102\u86CB\u767D\u904B\u9001\u3002 \u8F7D\u8102\u86CB\u767D\u5BC6\u5EA6\u53CA\u7ED3\u6784\u7C7B\u578B\u6C7A\u5B9A\u8BE5\u8F7D\u8102\u86CB\u767D\u5982\u4F55\u5C0D\u4EE3\u8B1D\u4EA7\u751F\u5F71\u97FF\u3002\u8840\u4E2D\u8102\u8D28(Lipid)\u4E3B\u8981\u7684\u6210\u5206\u6709\u81BD\u56FA\u9187(cholesterol; CE)\u3001\u4E09\u9178\u7518\u6CB9\u916F(triglyceride; TG)\u8207\u542B\u78F7\u8102\u7C7B(phospholipid)\uFF0C\u56E0\u4E0D\u6EB6\u65BC\u6C34\uFF0C\u5FC5\u9808\u5148\u8207\u8F7D\u8102\u86CB\u767DA\u0406\u3001\u8F7D\u8102\u86CB\u767DB100\u7D50\u5408\u6210\u53EF\u6EB6\u6027\u7684\u8102\u86CB\u767D(Lipoprotein)\u624D\u53EF\u904B\u884C\u65BC\u8840\u6DB2\u4E2D\uFF0C\u8F38\u9001\u5230\u5168\u8EAB\u5404\u90E8\u4F4D\u3002\u9AD8\u5BC6\u5EA6\u8102\u86CB\u767D(HDL-C)\u53EF\u4EE5\u79FB\u9664\u8840\u6DB2\u4E2D\u591A\u7684\u81BD\u56FA\u9187\uFF0C\u800C\u4F4E\u5BC6\u5EA6\u8102\u86CB\u767D(LDL-C)\u542B\u6709\u5927\u91CF\u81BD\u56FA\u9187\uFF0C\u5BB9\u6613\u9020\u6210\u52D5\u8108\u7CA5\u6837\u786C\u5316\u3002\u3002 \u9AD8\u8102\u8840\u75C7\u5206\u70BA\u300C\u539F\u767C\u6027\u300D\u548C\u300C\u7E7C\u767C\u6027\u4E9E\u578B\u300D\u3002\u539F\u767C\u6027\u9AD8\u8102\u8840\u75C7\u901A\u5E38\u4F86\u81EA\u65BC\u907A\u50B3\u539F\u56E0\uFF08\u4F8B\u5982\u5728\u53D7\u9AD4\u86CB\u767D\u4E2D\u7684\u7A81\u8B8A\uFF09\uFF0C\u800C\u7E7C\u767C\u6027\u9AD8\u8102\u8840\u75C7\u7684\u7522\u751F\u662F\u7531\u65BC\u5176\u5B83\u7684\u539F\u56E0\uFF0C\u5982\u7CD6\u5C3F\u75C5\u3002\u8102\u8CEA\u548C\u8102\u86CB\u767D\u7570\u5E38\u662F\u5728\u4E00\u822C\u4EBA\u7FA4\u8F03\u5E38\u898B\u7684\uFF0C\u4E26\u4E14\u88AB\u8A8D\u70BA\u662F\u5FC3\u8840\u7BA1\u75BE\u75C5\u7684\u4E00\u500B\u6539\u8B8A\u7684\u5371\u96AA\u56E0\u7D20\u3001\u8D77\u65BC\u52A8\u8109\u7CA5\u6837\u786C\u5316\u5C0D\u5B83\u5011\u767C\u751F\u5F71\u97FF\u3002\u6B64\u5916\uFF0C\u67D0\u4E9B\u5F62\u5F0F\u7684\u9AD8\u8102\u8840\u75C7\u53EF\u80FD\u8A98\u767C\u3002"@zh . . . . . . . . . . . . . . "\u0413\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F, \u0442\u0430\u043A\u043E\u0436 \u0433\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0435\u043C\u0456\u044F, \u0434\u0438\u0441\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F \u2014 \u0430\u043D\u043E\u043C\u0430\u043B\u044C\u043D\u043E \u043F\u0456\u0434\u0432\u0438\u0449\u0435\u043D\u0438\u0439 \u0440\u0456\u0432\u0435\u043D\u044C \u043B\u0456\u043F\u0456\u0434\u0456\u0432 \u0442\u0430/\u0430\u0431\u043E \u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0456\u0432 \u0443 \u043A\u0440\u043E\u0432\u0456 \u043B\u044E\u0434\u0438\u043D\u0438. \u0404 \u0441\u0438\u043D\u0434\u0440\u043E\u043C\u043E\u043C \u0434\u0435\u044F\u043A\u0438\u0445 \u0445\u0432\u043E\u0440\u043E\u0431. \u041F\u043E\u0440\u0443\u0448\u0435\u043D\u043D\u044F \u043E\u0431\u043C\u0456\u043D\u0443 \u043B\u0456\u043F\u0456\u0434\u0456\u0432 \u0442\u0430 \u043B\u0456\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0457\u043D\u0456\u0432 \u0437\u0443\u0441\u0442\u0440\u0456\u0447\u0430\u0454\u0442\u044C\u0441\u044F \u0434\u043E\u0432\u043E\u043B\u0456 \u0447\u0430\u0441\u0442\u043E \u0443 \u0437\u0430\u0433\u0430\u043B\u044C\u043D\u0456\u0439 \u043F\u043E\u043F\u0443\u043B\u044F\u0446\u0456\u0457. \u0413\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u044F \u0454 \u0432\u0430\u0436\u043B\u0438\u0432\u0438\u043C \u0444\u0430\u043A\u0442\u043E\u0440\u043E\u043C \u0440\u0438\u0437\u0438\u043A\u0443 \u0440\u043E\u0437\u0432\u0438\u0442\u043A\u0443 \u0441\u0435\u0440\u0446\u0435\u0432\u043E-\u0441\u0443\u0434\u0438\u043D\u043D\u0438\u0445 \u0437\u0430\u0445\u0432\u043E\u0440\u044E\u0432\u0430\u043D\u044C \u0443 \u0437\u0432'\u044F\u0437\u043A\u0443 \u0437\u0456 \u0437\u043D\u0430\u0447\u043D\u0438\u043C \u0432\u043F\u043B\u0438\u0432\u043E\u043C \u0445\u043E\u043B\u0435\u0441\u0442\u0435\u0440\u0438\u043D\u0443 \u043D\u0430 \u0440\u043E\u0437\u0432\u0438\u0442\u043E\u043A \u0430\u0442\u0435\u0440\u043E\u0441\u043A\u043B\u0435\u0440\u043E\u0437\u0443. \u041A\u0440\u0456\u043C \u0446\u044C\u043E\u0433\u043E, \u0434\u0435\u044F\u043A\u0456 \u0433\u0456\u043F\u0435\u0440\u043B\u0456\u043F\u0456\u0434\u0435\u043C\u0456\u0457 \u0432\u043F\u043B\u0438\u0432\u0430\u044E\u0442\u044C \u043D\u0430 \u0440\u043E\u0437\u0432\u0438\u0442\u043E\u043A \u0433\u043E\u0441\u0442\u0440\u043E\u0433\u043E \u043F\u0430\u043D\u043A\u0440\u0435\u0430\u0442\u0438\u0442\u0443."@uk . . . . . . . . . . . . . . . . . . . "Hiperlipidemia \u2013 zesp\u00F3\u0142 zaburze\u0144 metabolicznych objawiaj\u0105cych si\u0119 podwy\u017Cszonymi poziomami frakcji cholesterolu lub tr\u00F3jgliceryd\u00F3w w surowicy krwi. Najcz\u0119\u015Bciej spowodowana jest nieprawid\u0142owym od\u017Cywianiem, siedz\u0105cym trybem \u017Cycia, nadwag\u0105, predyspozycjami genetycznymi (hipercholesterolemia rodzinna). Prawid\u0142owe warto\u015Bci st\u0119\u017Cenia cholesterolu i trigliceryd\u00F3w \n* Cholesterol ca\u0142kowity: poni\u017Cej 200 mg/dl (5,2 mmol/l) \n* LDL-cholesterol: poni\u017Cej 135 mg/dl (3,5 mmol/l) \n* HDL-cholesterol (st\u0119\u017Cenie dla m\u0119\u017Cczyzn): powy\u017Cej 35 mg/dl (0,9 mmol/l) \n* HDL-cholesterol (st\u0119\u017Cenie dla kobiet): powy\u017Cej 50 mg/dl (1,3 mmol/l) \n* Tr\u00F3jglicerydy: poni\u017Cej 150 mg/dl (1,7 mmol/l) W zale\u017Cno\u015Bci od tego, wyr\u00F3\u017Cnia si\u0119 nast\u0119puj\u0105ce typy hiperlipidemii: \n* Hipercholesterolemia - przekroczony poziom cholesterolu \n* Hipertr\u00F3jglicerydemia - przekroczony poziom tr\u00F3jgliceryd\u00F3w \n* Hiperlipidemia mieszana - przekroczony poziom tr\u00F3jgliceryd\u00F3w oraz cholesterolu"@pl . . . . "\u0413\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F (\u0433\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u0435\u043C\u0438\u044F, \u0434\u0438\u0441\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F) \u2014 \u0430\u043D\u043E\u043C\u0430\u043B\u044C\u043D\u043E \u043F\u043E\u0432\u044B\u0448\u0435\u043D\u043D\u044B\u0439 \u0443\u0440\u043E\u0432\u0435\u043D\u044C \u043B\u0438\u043F\u0438\u0434\u043E\u0432 \u0438/\u0438\u043B\u0438 \u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u043E\u0432 \u0432 \u043A\u0440\u043E\u0432\u0438 \u0447\u0435\u043B\u043E\u0432\u0435\u043A\u0430. \u041D\u0430\u0440\u0443\u0448\u0435\u043D\u0438\u0435 \u043E\u0431\u043C\u0435\u043D\u0430 \u043B\u0438\u043F\u0438\u0434\u043E\u0432 \u0438 \u043B\u0438\u043F\u043E\u043F\u0440\u043E\u0442\u0435\u0438\u043D\u043E\u0432 \u0432\u0441\u0442\u0440\u0435\u0447\u0430\u0435\u0442\u0441\u044F \u0434\u043E\u0432\u043E\u043B\u044C\u043D\u043E \u0447\u0430\u0441\u0442\u043E \u0432 \u043E\u0431\u0449\u0435\u0439 \u043F\u043E\u043F\u0443\u043B\u044F\u0446\u0438\u0438. \u0413\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F \u044F\u0432\u043B\u044F\u0435\u0442\u0441\u044F \u0432\u0430\u0436\u043D\u044B\u043C \u0444\u0430\u043A\u0442\u043E\u0440\u043E\u043C \u0440\u0438\u0441\u043A\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u044F \u0441\u0435\u0440\u0434\u0435\u0447\u043D\u043E-\u0441\u043E\u0441\u0443\u0434\u0438\u0441\u0442\u044B\u0445 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0439 \u0432 \u043E\u0441\u043D\u043E\u0432\u043D\u043E\u043C \u0432 \u0441\u0432\u044F\u0437\u0438 \u0441\u043E \u0437\u043D\u0430\u0447\u0438\u0442\u0435\u043B\u044C\u043D\u044B\u043C \u0432\u043B\u0438\u044F\u043D\u0438\u0435\u043C \u0445\u043E\u043B\u0435\u0441\u0442\u0435\u0440\u0438\u043D\u0430 \u043D\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u0430\u0442\u0435\u0440\u043E\u0441\u043A\u043B\u0435\u0440\u043E\u0437\u0430. \u041A\u0440\u043E\u043C\u0435 \u044D\u0442\u043E\u0433\u043E, \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0435 \u0433\u0438\u043F\u0435\u0440\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u0438 \u0432\u043B\u0438\u044F\u044E\u0442 \u043D\u0430 \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u0435 \u043E\u0441\u0442\u0440\u043E\u0433\u043E \u043F\u0430\u043D\u043A\u0440\u0435\u0430\u0442\u0438\u0442\u0430. \u0434\u0438\u0441\u043B\u0438\u043F\u0438\u0434\u0435\u043C\u0438\u044F: \u043E\u0431\u0449\u0438\u0439 \u0425\u0421 > 5,0 \u043C\u043C\u043E\u043B\u044C/\u043B (190 \u043C\u0433/\u0434\u043B), \u0438\u043B\u0438 \u0425\u0421 \u041B\u041F\u041D\u041F > > 3,0 \u043C\u043C\u043E\u043B\u044C/ \u043B (115 \u043C\u0433/\u0434\u043B), \u0438\u043B\u0438 \u0425\u0421 \u041B\u041F\u0412\u041F < 1,0 \u043C\u043C\u043E\u043B\u044C/\u043B (40 \u043C\u0433/\u0434\u043B) \u0434\u043B\u044F \u043C\u0443\u0436\u0447\u0438\u043D \u0438 <1,2 \u043C\u043C\u043E\u043B\u044C/\u043B (46 \u043C\u0433/\u0434\u043B) \u0434\u043B\u044F \u0436\u0435\u043D\u0449\u0438\u043D, \u0438\u043B\u0438 \u0422\u0413 > 1,7 \u043C\u043C\u043E\u043B\u044C/\u043B (150 \u043C\u0433/\u0434\u043B);"@ru . . . . . . . . "Les hiperlip\u00E8mies, hiperlipoprote\u00EFn\u00E8mies, o hiperlipid\u00E8mies s\u00F3n el grup de dislip\u00E8mies m\u00E9s freq\u00FCents, i consisteixen en la pres\u00E8ncia de nivells elevats o anormals de l\u00EDpids i/o lipoprote\u00EFnes en la sang. Els l\u00EDpids (mol\u00E8cules greixos) s\u00F3n insolubles en la sang, i es transporten dins d'una c\u00E0psula lipoproteica, i la densitat dels l\u00EDpids i el tipus de prote\u00EFna determinen la sort de la part\u00EDcula i la seva influ\u00E8ncia en les anomalies del metabolisme. Les hiperlipid\u00E8mies es divideixen en dos subtipus: prim\u00E0ries i secund\u00E0ries. La hiperlipid\u00E8mia prim\u00E0ria sol ser deguda a causes gen\u00E8tiques (com ara una mutaci\u00F3 en una prote\u00EFna receptora), mentre que la hiperlipid\u00E8mia secund\u00E0ria sorgeix a causa d'altres causes subjacents com la diabetis. Les anomalies dels l\u00EDpids i les lipoprote\u00EFnes s\u00F3n freq\u00FCents en la poblaci\u00F3 general i es consideren factors de risc modificables de malalties cardiovasculars a causa de la seva influ\u00E8ncia sobre l'ateroesclerosi. A m\u00E9s, algunes formes poden predisposar a pancreatitis aguda"@ca . . . . . "Hiperlipidemia"@pl . . . . . . . . . . . . . . . . . . . . "\uACE0\uC9C0\uD608\uC99D(\u9AD8\u8102\u8840\u75C7, \uC601\uC5B4: hyperlipidemia, hyperlipoproteinemia, hyperlipidaemia)\uC740 \uD544\uC694 \uC774\uC0C1\uC758 \uC9C0\uBC29\uC131\uBD84 \uBB3C\uC9C8\uC774 \uD608\uC561\uC5D0 \uC874\uC7AC\uD558\uC5EC \uC5FC\uC99D\uC744 \uC77C\uC73C\uD0A4\uB294 \uC0C1\uD0DC \uB610\uB294 \uD608\uCCAD \uC18D\uC5D0 \uC9C0\uBC29\uC9C8\uC774 \uB9CE\uC544\uC11C \uD608\uCCAD\uC774 \uD63C\uD0C1\uD574\uC9C4 \uC0C1\uD0DC\uB97C \uB9D0\uD55C\uB2E4. \uACE0\uC9C0\uC9C8 \uD608\uC99D(\u9AD8\u8102\u8CEA\u8840\u75C7)\uC774\uB77C\uACE0\uB3C4 \uD55C\uB2E4. \uACF5\uBCF5\uC2DC \uD608\uCCAD \uCF5C\uB808\uC2A4\uD14C\uB864\uC774 220 mg/dl \uC774\uC0C1\uC774\uAC70\uB098 \uC911\uC131\uC9C0\uBC29\uC774 150 mg/dl\uC774\uC0C1\uC778 \uACBD\uC6B0 \uACE0\uC9C0\uD608\uC99D\uC73C\uB85C \uC9C4\uB2E8\uD55C\uB2E4. \uACE0\uC9C0\uD608\uC99D\uC740 \uADF8 \uC790\uCCB4\uB85C \uD2B9\uBCC4\uD55C \uC99D\uC0C1\uC774 \uB098\uD0C0\uB098\uC9C0\uB294 \uC54A\uC9C0\uB9CC, \uACE0\uD608\uC555, \uB3D9\uB9E5\uACBD\uD654, \uB1CC\uC878\uC911 \uB4F1\uC744 \uCD09\uC9C4\uC2DC\uD0A4\uB294 \uC704\uD5D8\uC694\uC778\uC73C\uB85C\uC11C \uC2EC\uD608\uAD00\uACC4 \uC9C8\uD658\uC5D0 \uC758\uD55C \uC0AC\uB9DD\uC728\uC744 \uC720\uC758\uD558\uAC8C \uC99D\uAC00\uC2DC\uD0A8\uB2E4. \uC774 \uBCD1\uC744 \uCE58\uB8CC\uD558\uAE30 \uC704\uD574\uC11C\uB294 \uC6B4\uB3D9\uC694\uBC95\uACFC \uC2DD\uC774\uC694\uBC95\uC774 \uBCD1\uD589\uB418\uC5B4\uC57C \uD558\uBA70, \uB2EC\uCF64\uD55C \uC74C\uC2DD\uC774\uB098 \uC54C\uCF54\uC62C \uC74C\uB8CC \uB4F1\uC744 \uD53C\uD574\uC57C \uD55C\uB2E4. \uB2E4\uB9CC, \uC9C0\uC9C8\uC758 \uB18D\uB3C4\uAC00 \uAD00\uB9AC\uB418\uC9C0 \uC54A\uB294 \uD658\uC790\uB4E4\uC740 \uC2A4\uD0C0\uD2F4(statin)\uC744 \uBE44\uB86F\uD55C \uC57D\uC744 \uC774\uC6A9\uD558\uC5EC \uD608\uC911 \uC9C0\uC9C8\uC744 \uC870\uC808\uD558\uC5EC \uC2EC\uD608\uAD00\uACC4 \uC9C8\uD658\uC758 \uC704\uD5D8\uC131\uC744 \uB0AE\uCD9C \uD544\uC694\uAC00 \uC788\uB2E4."@ko .